3D Cell Culture 2019 Conference

Documentation - February 20-21, 2019- London, United Kingdom

Conference Proceedings

Standard Price

US$ 616.05

Change your currency: USD EUR GBP

User Details

Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring, cell viability, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans.

Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting, funding from governments and private entities and technological advancements in the field.

Join us in February 2019, as we look at the latest developments in the 3D Cell Culture field. Network with industry experts, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development, discuss the potential for novel in-vitro cell culture models to replace animal models, and discover novel 3D cell culture systems, organ-on-chip, 3D imaging of organoids and other technologies in development.

Benefits of Attending

The 3D Cell Culture field is rapidly evolving. Each year, new technologies are being developed, promoting exponential growth and development within the industry. Developing on last years' success, this must-attend conference will bring together industry experts to discuss and analyze the latest advancement and challenges within 3D Cell Culture.

At our 3rd Annual 3D Cell Culture Conference, you will gain insight into:

  • Organ-on-chip technologies and their applications in the pharmaceutical industry
  • Panel discussion on whether 3D Cell Culture will replace animal models
  • Determining the predictive validity of 3D models and achieving standardization for preclinical testing
  • Global developments in 3D Cell Culture and how this exponential growth will impact researchers
  • Several novel techniques for imaging of 3D Cell Cultures
  • Development of 3D eye models for early assessment of retinal toxicity
  • Musculoskeletal regeneration harnessing preclinical models for tissue repair

Plus an Interactive Half-Day Pre-Conference Workshop | Tuesday 19th February 2018

3D you can see - planar 3D spheroid arrays for histology
Workshop Leaders: Dr. Patrick Kugelmeier, Founder, Director of Science, Kugelmeiers
Dr. Michael Raghunath, Professor for Biochemistry, Protein Technology and Tissue Engineering, Zurich University of Applied Sciences    
8.30 - 12.30


  • Anne Rios, Principal Investigator, Princess Maxima Center
  • Asli Akidil, Cell and Molecular Scientist , AstraZeneca
  • Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience
  • Helena Hogberg, Deputy Director, Center for Alternatives to Animal Testing, Johns Hopkins University Bloomberg School of Public Health
  • Heloise Ragelle, Postdoctoral researcher, Roche
  • Himjyot Jaiswal, Senior Scientist, Novo Nordisk
  • Jason Ekert, Head of Complex In Vitro Models, GSK
  • Kevin Fournier, Sales and Applications Manager, Poietis
  • Krzysztof Wrzesinski, CSO/Founder, CelVivo ICS
  • Majilida Lako, Professor of Stem Cell Science, Newcastle University
  • Marta Rucka, Product Manager, Promega
  • Melanie Matheu, Founder, CEO , Prellis Biologics
  • Michael Raghunath, Head Center for Cell Biology & Tissue Engineering Director Competence Center TEDD, Zurich University of Applied Sciences
  • Michele Zagnoni, Senior Lecturer, University Of Strathclyde
  • Nicola Valeri, Team Leader, The Institute of Cancer Research
  • Patrick Kugelmeier, Director of Science, Kugelmeiers
  • Philip Hewitt, Head of Early Investigative Toxicology, Merck KGaA
  • Richard Oreffo, Director, Centre for Human Development, University Of Southampton
  • Robert Vries, Managing Director, Hubrecht Institute
  • Sally Price, Head of Cell and Translational Science, Medicines Discovery Catapult
  • Samuel Jackson, Programme Manager, Disease Models, NC3Rs
  • Stefan Kustermann, Lab Head, Roche
  • Stefan Przyborski, Proessor of Cell Technology, University of Durham
  • Veronique Barban, Expert Virology, Research and Nonclinical Safety Department , Sanofi Pasteur
  • William Mattes, Director, Division of Systems Biology, U.S. Food and Drug Administration
  • Wouter Strijker, Business Developer, Mimetas

Please fill in your name and email to receive the Conference Agenda of this event.


Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK


Copthorne Tara Hotel
Scarsdale Place, Kensington
London, United Kingdom
3D Cell Culture
Event details
Organizer :SAE Media Group
Event type :Conference
Attendance :Physical Event
Reference :ASDE-19066